Peter H. Calcott, VP, Quality & Compliance at PDL BIOPHARMA, INC. (PDLI), sold 625 shares at $20.34 ($13K) on 2006-10-10, disclosed to the SEC on 2006-10-12.
Scheduled sale ($13k) by VP, Quality & Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |